Table 2. Subject demographics of the CREG participants for whom plasma adropin values were measured for the weight loss study.

Data are mean ± SE.

Demographic; laboratory measurement	All participants	CR	CREX	EX
Gender (F/M, n)	42/12	13/3	16/4	13/5
Age (years)	57.0 ± 0.7	57.4 ± 1.4	57.2 ± 1.2	56.9 ± 1.3
Weeks taken to attain weight loss goals*	17.0 ± 1.1	18.6 ± 1.8	13.5 ± 1.7*	19.4 ± 1.8
BMI (kg/m2)1
Pre treatment	27.7 ± 0.2	27.7 ± 0.4	28.3 ± 0.4	27.0 ± 0.4
Post treatment	25.9 ± 0.2	25.9 ± 0.4	26.3 ± 0.4	25.4 ± 0.4
Change	−1.8 ± 0.1	−1.7 ± 0.2	−2.0 ± 0.2	−1.6 ± 0.2
Body weight (kg)1
Pre treatment	78.7 ± 1.4	77.2 ± 2.0	81.8 ± 1.8	76.5 ± 1.9
Post treatment	73.5 ± 1.4	72.2 ± 2.0	75.9 ± 1.8	72.0 ± 1.9
Change	−5.2 ± 0.3	−5.0 ± 0.5	−5.9 ± 0.5	−4.5 ± 0.5
Fat mass (kg)1
Pre treatment	31.8 ± 0.7	32.0 ± 1.3	33.1 ± 1.1	30.3 ± 1.2
Post treatment	27.6 ± 0.7	28.1 ± 1.3	28.3 ± 1.1	26.4 ± 1.2
Change	−4.3 ± 0.3	−3.9 ± 0.5	−4.8 ± 0.4	−3.9 ± 0.4
Fat-free mass (kg)1
Pre treatment	46.5 ± 1.2	44.9 ± 1.1	48.3 ± 1.0	45.9 ± 1.1
Post treatment	45.8 ± 1.2	44.0 ± 1.1	47.5 ± 1.0	45.7 ± 1.0
Change	−0.6 ± 1.2	−0.8 ± 0.3	−0.8 ± 0.2	−0.2 ± 0.3
Fat%1
Pre treatment	42.2 ± 0.8	43.4 ± 1.0	42.2 ± 0.9	41.2 ± 0.9
Post treatment	39.1 ± 0.9	40.7 ± 1.1	38.8 ± 1.0	37.9 ± 1.0
Change	−3.2 ± 0.2	−2.7 ± 0.4	−3.4 ± 0.4	−3.3 ± 0.4

¹Sex was used as a covariate in the analysis to adjust for differences in proportion of males and females in each group.

^*Among group comparison by ANOVA, P<0.05; CREX vs. CR, EX P<0.05.